Dr. Amrit Seetharam – CurAccel

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” gap=”25″ equal_height=”yes” css=”.vc_custom_1510113762967{background-color: #e4ebf3 !important;}”][vc_column width=”1/3″][/vc_column][vc_column width=”1/3″][vc_empty_space][vc_single_image image=”3931″ img_size=”large” alignment=”center” qode_css_animation=””][vc_column_text]CurAccel

 

 [/vc_column_text][/vc_column][vc_column width=”1/3″][/vc_column][/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1510113771206{background-color: #e4ebf3 !important;}”][vc_column width=”1/4″][/vc_column][vc_column width=”1/2″][vc_column_text css=”.vc_custom_1541395822722{padding-right: 10px !important;padding-left: 10px !important;}”]

Dr. Seetharam has over 20 years of clinical research experience within the biopharmaceutical and academic sectors with a focus in quality and data integrity.  While trained in Neurology, Dr. Seetharam has expanded his expertise in the areas of oncology, neurology, ophthalmology, Infectious Disease, CNS, CVS, Endocrine, and Rare/Orphan disease indications in both adult and pediatric populations.

 

Grounded from a quality oversight background at another CRO, Dr. Seetharam has been with CurAccel since its inception leading the organization’s growth into being a leader in CRO services that is known for its innovative and forward thinking approach.  Prior to joining CurAccel, Dr. Seetharam has had key leadership roles at other CROs as well as biotechnology and pharmaceutical companies.

 

His leadership at CurAccel has been pivotal in providing a competitive reach in the global market especially in the successful execution of conventional and non-conventional clinical trials.  He has been instrumental in delivering countless investigational drugs and devices to market.

[/vc_column_text][vc_empty_space height=”50px”][/vc_column][vc_column width=”1/4″][/vc_column][/vc_row]